These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26276305)

  • 1. Glasgow Antipsychotic Side-effects Scale for Clozapine - Development and validation of a clozapine-specific side-effects scale.
    Hynes C; Keating D; McWilliams S; Madigan K; Kinsella A; Maidment I; Feetam C; Drake RJ; Haddad PM; Gaughran F; Taylor M; Clarke M
    Schizophr Res; 2015 Oct; 168(1-2):505-13. PubMed ID: 26276305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Validation of the Dutch Glasgow Anti- psychotic Side-Effect Scale for Clozapine].
    Huisman R; Okhuijsen-Pfeifer C; Mulder EYH; Jongkind A; Cohen D; Bogers JPAM; van der Horst MZ; Luykx JJ
    Tijdschr Psychiatr; 2021; 63(4):270-275. PubMed ID: 33913142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability of the Glasgow Antipsychotic Side-effects Scale for Clozapine Japanese version (GASS-C-J).
    Kitagawa K; So R; Nomura N; Mizuno Y; Misawa F; Kodama M; Uchida H; Mimura M; Takeuchi H
    PLoS One; 2020; 15(6):e0234864. PubMed ID: 32555706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Glasgow antipsychotic side-effects scale for clozapine in inpatients and outpatients with schizophrenia or schizoaffective disorder.
    Ignjatović Ristić D; Cohen D; Obradović A; Nikić-Đuričić K; Drašković M; Hinić D
    Nord J Psychiatry; 2018 Feb; 72(2):124-129. PubMed ID: 29125018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new self-rating scale for detecting atypical or second-generation antipsychotic side effects.
    Waddell L; Taylor M
    J Psychopharmacol; 2008 May; 22(3):238-43. PubMed ID: 18541624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translation and cultural adaptation of Glasgow Antipsychotic Side-effects Scale (GASS) in Arabic.
    AlRuthia Y; Alkofide H; Alosaimi FD; Alkadi H; Alnasser A; Aldahash A; Basalamah A; Alarfaj M
    PLoS One; 2018; 13(8):e0201225. PubMed ID: 30138349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interrater reliability of the Antipsychotic Non-Neurological Side-Effects Rating Scale measured in patients treated with clozapine.
    Ohlsen RI; Williamson R; Yusufi B; Mullan J; Irving D; Mukherjee S; Page E; Aitchison KJ; Barnes TR
    J Psychopharmacol; 2008 May; 22(3):323-9. PubMed ID: 18541627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and nature of side effects during clozapine maintenance treatment and the relationship with clozapine dose and plasma concentration.
    Yusufi B; Mukherjee S; Flanagan R; Paton C; Dunn G; Page E; Barnes TR
    Int Clin Psychopharmacol; 2007 Jul; 22(4):238-43. PubMed ID: 17519648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Audit: Monitoring of side effects using GASS (Glasgow Antipsychotic Side-Effect Scale).
    Iankov B; Prabhakar S; Rahman A; Hosseini F
    Psychiatr Danub; 2017 Sep; 29(Suppl 3):685-686. PubMed ID: 28953853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Side-effects and treatment with clozapine: a comparison between the views of consumers and their clinicians.
    Hodge K; Jespersen S
    Int J Ment Health Nurs; 2008 Feb; 17(1):2-8. PubMed ID: 18211398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the Glasgow Antipsychotic Side-Effect Scale (GASS) in an Italian Sample of Patients with Stable Schizophrenia and Bipolar Spectrum Disorders.
    Rodolico A; Concerto C; Ciancio A; Siafis S; Fusar-Poli L; Romano CB; Scavo EV; Petralia A; Salomone S; Signorelli MS; Leucht S; Aguglia E
    Brain Sci; 2022 Jul; 12(7):. PubMed ID: 35884698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatic tolerance of atypical antipsychotic drugs].
    Dumortier G; Cabaret W; Stamatiadis L; Saba G; Benadhira R; Rocamora JF; Aubriot-Delmas B; Glikman J; Januel D
    Encephale; 2002; 28(6 Pt 1):542-51. PubMed ID: 12506267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder.
    Byerly MJ; Nakonezny PA; Rush AJ
    Schizophr Res; 2008 Mar; 100(1-3):60-9. PubMed ID: 18255269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical drug monitoring in child and adolescent psychiatry: side effects of atypical neuroleptics.
    Fleischhaker C; Heiser P; Hennighausen K; Herpertz-Dahlmann B; Holtkamp K; Mehler-Wex C; Rauh R; Remschmidt H; Schulz E; Warnke A
    J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):308-16. PubMed ID: 16768638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
    Wheeler AJ
    Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial.
    Zink M; Kuwilsky A; Krumm B; Dressing H
    J Psychopharmacol; 2009 May; 23(3):305-14. PubMed ID: 18562423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability and validity of the Japanese version of the Recovery Assessment Scale (RAS) for people with chronic mental illness: scale development.
    Chiba R; Miyamoto Y; Kawakami N
    Int J Nurs Stud; 2010 Mar; 47(3):314-22. PubMed ID: 19679304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia.
    Lewis SW; Barnes TR; Davies L; Murray RM; Dunn G; Hayhurst KP; Markwick A; Lloyd H; Jones PB
    Schizophr Bull; 2006 Oct; 32(4):715-23. PubMed ID: 16540702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Switching from clozapine to zotepine in patients with schizophrenia: a 12-week prospective, randomized, rater blind, and parallel study.
    Lin CC; Chiu HJ; Chen JY; Liou YJ; Wang YC; Chen TT; Bai YM
    J Clin Psychopharmacol; 2013 Apr; 33(2):211-4. PubMed ID: 23422395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of an Italian version of the functional index for hand osteoarthritis (FIHOA).
    Gandini F; Giannitti C; Fattore G; Giordano N; Galeazzi M; Fioravanti A
    Mod Rheumatol; 2012 Sep; 22(5):758-65. PubMed ID: 22245976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.